ARCT
#3021
Arcturus Therapeutics Holdings Inc. - Common Stock
15.1 9 USD
-0.06%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-6.06%
Variación mensual
+155.72%
Variación en los últimos 6 meses
+90.83%
Cambio anual
-10.65%
Cierres anteriores
16.1 7
Open
15.1 9
Mínimo
15.1 9
Máximo
15.1 9
Volumen
49
Financials
- Market Capitalization 431.75 M
- Employee 111
- Founded 2013
- CEO Joseph E. Payne
- Website www.arcturusrx.com
- Headquarter Delaware, United States
- FIGI BBG00NNW8JK1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.02
Relación precio/flujo de caja
6.28
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3011 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 5.47 USD | -13.72% | -17.50% | +7.89% | +355.83% | 436.53 M USD | ||
| 3020 |  CMPX Compass Therapeutics, Inc. - Common Stock | 2.40 USD | -4.76% | -0.41% | +22.45% | -30.43% | 432.21 M USD | ||
| 3025 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 12.27 USD | +4.25% | +9.07% | +23.94% | +37.09% | 430.27 M USD | ||
| 3026 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 5.36 USD | -1.65% | -0.56% | +13.08% | +66.98% | 429.90 M USD |